DOI:

Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography

Shuzou Tanimoto, MD; Jiro Aoki, MD; Patrick W. Serruys, MD, PhD; Evelyn Regar*, MD, PhD

A 73-year-old woman with hypertension, hyperlipidemia and positive familial history of coronary artery disease presented with Canadian Cardiovascular Society class III angina and underwent coronary angiography, which showed a chronic occluded right coronary artery (Panel A). The vessel was recanalized and treated with three paclitaxel-eluting stents (TAXUS®, Boston Scientific: 3.5 x 32 mm distally, 3.5 x 28 mm in the middle part, 3.5 x 12 mm proximally). Postintervention coronary angiography showed a good result (Panel B). Twelve-month follow-up angiography revealed focal in-stent restenosis (Panel C). Intracoronary optical coherence tomography (OCT: LightLabImaging™, Boston, MA, USA) pullback displayed well-expanded stents covered with a thin, homogenous, highly reflective neointimal layer (Panel D, E). In contrast, the narrowest lesion site (minimal lumen area 1.1 mm2; stent area 9.0 mm2) showed a three-layer appearance of the neointima (Panel F). The inner luminal layer appeared concentric, homogenous and signal-rich (maximal thickness 0.27 mm). A second layer consisting of a low-reflective area with poorly delineated borders followed. The third layer was in direct contact with the stent struts and revealed only minimal signal intensity. These signal-poor areas (maximal thickness 1.18 mm) might represent acellular fibrinoid deposition that has been well described in experimental studies. The patient was re-treated with repeat paclitaxel-eluting stent implantation.

OCT is an analogue of intravascular ultrasound with an ultra-high resolution (10 µm) superior to any current available imaging modalities. This imaging device may be useful in visualizing neointimal growth in drug-eluting stents and improve our understanding of its underlying physiopathology in the future.

Volume 1 Number 4
Feb 20, 2006
Volume 1 Number 4
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-25-00025 Aug 18, 2025
Does a positive bubble study after PFO closure matter: is it much ado about nothing or an indication for reintervention?
Horlick E and Abrahamyan L
free

Research Correspondence

10.4244/EIJ-D-25-00125 Aug 18, 2025
A randomised controlled trial of the Cathpax AIR radioprotection cabin during cardiology procedures
Merieau A et al

Letter to the editor

10.4244/EIJ-D-25-00472 Aug 18, 2025
Letter: Complex PCI in severe aortic stenosis: high risk, low reward?
Ktenopoulos N et al

Editorial

10.4244/EIJ-E-25-00036 Aug 18, 2025
“He who has eyes to see, let him see”
Garcia-Garcia H
free

Letter to the editor

10.4244/EIJ-D-25-00542 Aug 18, 2025
Reply: Complex PCI in severe aortic stenosis: high risk, low reward?
Munafò A and Montalto C
Trending articles
95.75

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.8

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved